BENJAMIN BOVE

CHAIRMAN, PRESIDENT AND CEO

Ben is Chairman, President, and CEO of NOVOS Growth Partners (NGP). Ben has extensive experience transforming performance and stepchanging growth across numerous industries. Over the last ten years, he has led numerous pharmaceutical turnarounds and product launches across multiple therapeutic classes via strategies focused on growth and capital efficiency with a heavy emphasis on analytics and innovation. Ben was previously SVP and GM, Primary Care Business Unit and Strategy and Analytics at Horizon Pharma where he played a key role in transforming the company and increasing its share price by 15x over three years. Prior to Horizon, he was at Galt and Company, a boutique management consulting firm that focuses exclusively on developing transformational and high-growth strategies for Fortune 200 companies. Ben serves on multiple boards across pharma, technology, and the nonprofit sectors. He holds a Master of Business Administration, Master of Engineering Management, and a Bachelor of Sciences in Mechanical Engineering, each from Northwestern University.

DAN WALLENBERG

EVP COMPREHENSIVE COMMERCIAL PLATFORM AND VALINOR CHIEF COMMERCIAL OFFICER

Dan is Chief Commercial Officer, leading new product launches, M&A, and new business assessment and builds, while also supporting key innovation initiatives. Dan has 15+ years of entrepreneurship, management consulting and M&A experience across a wide range of industries. Dan is a proven leader and entrepreneur with a track record of driving profitable growth for businesses at all stages of development. Prior to NGP, Dan was a partner at Galt and Company, a management consulting firm, where he advised management teams and investors on growth strategy, M&A, and investment opportunities to dramatically improve the value of their business. Dan holds a Bachelor of Science in Engineering and Technology Management from the University of Illinois

GREG BASS

EVP GLOBAL MARKET ACCESS AND SUPPLY CHAIN

Greg is Executive Vice President and leads the Global Access team. With over 20 years of industry experience, Greg brings a breadth and depth of functional knowledge and experience with a proven track record of driving top line and bottom line revenue growth in large, midsize and innovative start-up biopharma companies. Throughout his career, Greg has launched numerous products, including blockbuster oncology and immunology therapies. Prior to joining NGP, he was Executive Vice President and Chief Commercial Officer at Lipocine, Inc. Previously, he held various roles at Pfizer, Johnson & Johnson and Merz GmbH. Greg holds a Bachelor of Arts in Biology (cum laude) from Brandeis University

JEFF DOW

EVP COMMERCIAL ANALYTIC TECHNOLOGIES

Jeff is an Executive Vice President and leads the Data, Technology and Analytics team. He has ten years of pharma analytics experience, spanning multiple therapeutic areas with extensive expertise in marketing and commercial analytics. Prior to pharma, Jeff worked in various data, technology, and analytics roles in the media sector, including Starcom Mediavest Group and Publicis Media. He holds a Bachelor of Arts in both Economics and Computing & Information Sciences from Northwestern University.

STEVE CURTIS

EVP APOLLO CARE

Steve is Executive Vice President managing Apollo Copay and NOVOS Patient Solutions, a subsidiary of NGP, where he leads all commercial operations. Steve has extensive commercial leadership experience at Horizon Pharma plc and other NGP partners. Steve now applies his deep commercial experience to build best-in-class tools to support industry leading brands. Steve holds a Bachelor of Science in Finance and Marketing from the University of Utah and a MBA The Wharton School University of Pennsylvania.

MICHAEL V. AQUILINO

CHIEF FINANCIAL OFFICER

Michael is Chief Financial Officer. He has spent the last ten years in finance and consulting leadership roles and has extensive experience designing, building, and managing finance departments across numerous companies in the pharmaceutical and healthcare industries. Prior to his time in pharma, Michael was a Vice President at Avondale Strategic Partners and has also worked as an independent trader in the U.S. treasury bonds and notes market. He holds a Bachelor of Arts in Economics from the University of Michigan.

SUZANNE VONDRUSKA

VICE PRESIDENT, HUMAN RESOURCES AND BUSINESS OPERATIONS

Suzanne is Vice President of Human Resources and Business Operations. She is responsible for all human resources policies, programs and services for the organization and affiliates, while also overseeing necessary business operations functions. She has been instrumental in integrating human resources and business operations initiatives into the strategic goals of the organization. Suzanne has more than ten years of experience in administration and human resources spanning legal, retail, consulting and pharmaceutical industries. She is an active member of the national and local chapters of the Society of Human Resource Management and pursuing a senior professional human resources designation. She holds a Bachelor of Arts in Liberal Arts and Sciences from the University of Illinois Urbana-Champaign.

JENNIFER ANGLIN

VICE PRESIDENT, NOVOS GROWTH

Jen is Vice President of Operations leading client support and delivery teams. Jen has spent the last fifteen years supporting client relationships in a variety of industries and the last six years specifically in specialty pharma. She has applied her previous strategy consulting experience to build unique client operational environments and leading the NOVOS sales operations team. Jen earned her CPA and a Bachelor of Science in Accountancy from the University of Illinois Urbana-Champaign.